Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Pyxis Oncology (PYXS) Non Operating Investment Income (2024 - 2025)

Historic Non Operating Investment Income for Pyxis Oncology (PYXS) over the last 2 years, with Q3 2025 value amounting to $74000.0.

  • Pyxis Oncology's Non Operating Investment Income fell 8366.45% to $74000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was -$282000.0, marking a year-over-year change of. This contributed to the annual value of $107000.0 for FY2024, which is 6984.13% up from last year.
  • As of Q3 2025, Pyxis Oncology's Non Operating Investment Income stood at $74000.0, which was down 8366.45% from -$54000.0 recorded in Q2 2025.
  • Pyxis Oncology's 5-year Non Operating Investment Income high stood at $453000.0 for Q3 2024, and its period low was -$181000.0 during Q4 2024.